Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

Delayed Data
As of Apr 27
 +0.63 / +1.32%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 47.00, with a high estimate of 66.00 and a low estimate of 17.00. The median estimate represents a -1.18% decrease from the last price of 47.56.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in Ionis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -79.22%
Growthannually 40.63%


Growthquarterly -27.92%
Growthannually 21.69%
Key to the earnings and sales forecast charts.